Recent Posts

• Exactis, in top clinical trial companies based in Canada
• Newsletter #11 – May 5, 2021
• Exactis’ is pleased to announce their latest publication in Clinical and Translational Medicine entitled “Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer”.
• Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
• The Next Steps for Precision Oncology in Canada